Hepatic Lipidosis in Dairy Cows: A Transition-Period Disorder With Systemic Consequences

In modern dairy production systems, the transition period represents a critical physiological bottleneck where metabolic adaptation determines health, productivity, and longevity of the cow. This phase, spanning three weeks before and after parturition, is characterized by dramatic endocrine, metabolic, and immunological shifts aimed at supporting colostrum synthesis and the onset of lactation. When these adaptive mechanisms fail, metabolic disorders emerge, among which hepatic lipidosis (fatty liver disease) is one of the most prevalent yet underdiagnosed conditions affecting high-producing dairy cows¹. 

Transition Physiology and the Central Role of the Liver 

The liver functions as the primary metabolic regulator during the transition period, coordinating glucose production, lipid metabolism, ketogenesis, and detoxification processes. In early lactation, glucose demand rises sharply for lactose synthesis, while dry matter intake lags behind energy requirements. This imbalance forces cows into a state of negative energy balance (NEB), prompting extensive mobilization of adipose tissue reserves². 

Under normal physiological conditions, the liver adapts to this challenge. However, in high-yielding cows, metabolic demand may exceed hepatic functional capacity, resulting in lipid accumulation, oxidative stress, inflammation, and progressive hepatocellular dysfunction³. 

Fatty Liver: A Metabolic Overflow Disorder 

Hepatic lipidosis develops when excessive quantities of non-esterified fatty acids (NEFAs) enter the liver and overwhelm its capacity for oxidation and triglyceride export as very-low-density lipoproteins (VLDL). Due to the inherently low VLDL export capability of bovine hepatocytes, triglycerides accumulate intracellularly, leading to varying degrees of fatty infiltration¹. 

Fat accumulation typically begins two to three weeks before calving, peaks shortly after parturition, and gradually resolves if metabolic balance is restored. However, when lipid infiltration exceeds adaptive limits, the liver becomes functionally compromised, predisposing cows to secondary metabolic and infectious diseases¹. 

Predisposing Factors Observed at Herd Level 

From a herd-health perspective, hepatic lipidosis is strongly linked to body condition management and periparturient feeding strategies. Overconditioned cows entering the dry period exhibit exaggerated fat mobilization postpartum, resulting in higher circulating NEFA concentrations and increased hepatic fat deposition^4. 

Additional risk factors include: 

• Excessive body condition score (>3.5) at calving 

• Prolonged dry periods 

• Reduced postpartum appetite 

• Insulin resistance during late gestation 

• High genetic merit for milk production 

Heifers are particularly vulnerable due to limited metabolic flexibility, while cows with extended dry periods often develop obesity, increasing the likelihood of postpartum liver steatosis¹. 

Hormonal and Metabolic Dysregulation 

Hormonal changes during early lactation amplify lipid mobilization. Reduced insulin concentrations and insulin resistance promote adipose tissue lipolysis, while decreased insulin-like growth factor-I (IGF-I) impairs anabolic recovery. Loss of hepatic growth hormone receptor activity further reduces IGF-I synthesis, limiting metabolic adaptation during peak energy demand¹. 

Simultaneously, low cortisol levels in the immediate postpartum period impair gluconeogenesis while enhancing ketogenesis and lipogenesis, intensifying hepatic lipid accumulation and increasing the risk of concurrent ketosis^2. 

Systemic Impact of Hepatic Lipidosis 

Fatty liver should not be viewed as an isolated hepatic condition. Instead, it represents a systemic metabolic disorder with widespread clinical implications. Impaired liver function compromises immune response, reduces detoxification capacity, and disrupts nutrient metabolism, leading to increased disease susceptibility¹. 

Clinically, affected cows demonstrate higher incidence of: 

• Clinical and subclinical ketosis 

• Retained fetal membranes 

• Metritis and mastitis 

• Displaced abomasum 

• Reduced conception rates 

• Prolonged calving intervals 

• Decreased milk yield and persistency 

Severe cases may progress to hepatic encephalopathy, characterized by neurological dysfunction and high mortality risk¹. 

Hemato-Biochemical Indicators: Interpreting Patterns Rather Than Values 

Biochemical profiling remains an important supportive tool for assessing liver health, although no single marker is pathognomonic. Elevated NEFA and β-hydroxybutyrate (BHB) concentrations reflect energy imbalance, while changes in hepatic enzymes indicate hepatocellular stress. 

Among liver enzymes, aspartate aminotransferase (AST) has consistently demonstrated the strongest association with the severity of hepatic fat infiltration. Increased AST activity correlates with hepatocyte damage caused by triglyceride accumulation, making it the most sensitive biochemical indicator during the transition period³. 

Alterations commonly include: 

• Increased AST, NEFA, and BHB 

• Decreased glucose, cholesterol, albumin, and insulin 

• Mild or inconsistent changes in GGT and ALP 

These patterns are especially pronounced in early lactation and tend to normalize as energy balance improves². 

Diagnostic Challenges and Practical Approaches 

Early diagnosis of hepatic lipidosis remains challenging due to delayed biochemical responses and non-specific clinical signs. Traditional liver enzyme testing often detects damage only after significant fat infiltration has occurred, limiting therapeutic success¹. 

A practical diagnostic strategy should include: 

1. Identification of high-risk transition cows 

2. Monitoring of body condition and feed intake 

3. Measurement of NEFA and BHB for NEB assessment 

4. Interpretation of AST trends rather than absolute values 

5. Use of transcutaneous ultrasonography for moderate-to-severe cases 

6. Application of fine-needle aspiration cytology (FNAC) for early detection when feasible 

FNAC has shown acceptable sensitivity and specificity for detecting early hepatic triglyceride accumulation and represents a valuable field-level diagnostic adjunct⁵. 

Preventive Focus: Managing Energy Balance, Not Just Disease 

Given the multifactorial nature of fatty liver disease, prevention is far more effective than treatment. Management strategies should prioritize maintaining optimal energy balance and minimizing excessive lipid mobilization during the transition period. 

Key preventive measures include: 

• Avoiding overconditioning during late lactation and dry period 

• Encouraging consistent dry matter intake before and after calving 

• Reducing environmental and social stressors 

• Optimizing cow comfort and feeding frequency 

Nutritional interventions such as rumen-protected choline supplementation have demonstrated efficacy in reducing hepatic fat accumulation by improving triglyceride export from the liver, whereas other additives show variable benefits⁶. 

Final Perspective 

Hepatic lipidosis is a hallmark metabolic disorder of the transition period, reflecting the inability of the dairy cow to adapt to sudden and extreme energy demands. Its presence signals broader metabolic instability and predicts poor health, reduced fertility, and economic loss. As dairy systems continue to push for higher productivity, greater emphasis must be placed on transition cow management, early metabolic monitoring, and preventive nutrition. 

Improving our understanding of hepatic metabolic adaptation during this critical window will remain central to enhancing animal welfare, reproductive efficiency, and sustainable milk production in modern dairy herds. 

References 

1. Bombik E, Sokol J, Pietrzkiewicz K. Fatty liver disease in dairy cattle–risk factors, symptoms and prevention. Roczniki Naukowe Polskiego Towarzystwa Zootechnicznego. 2021;16(4):51-8. https://bibliotekanauki.pl/articles/2119575.pdf 

2. Grzybowska D, Sobiech P, Tobolski D. Ultrasonographic image of fatty infiltration of the liver correlates with selected biochemical parameters and back fat thickness of periparturient Holstein-Friesian cows. Polish Journal of Veterinary Sciences. 2023:723-32. https://journals.pan.pl/Content/129601/PDF-MASTER/20%20_%20Grzybowska.pdf 

3. Zhang C, Shao Q, Liu M, Wang X, Loor JJ, Jiang Q, Cuan S, Li X, Wang J, Li Y, He L. Liver fibrosis is a common pathological change in the liver of dairy cows with fatty liver. Journal of Dairy Science. 2023 Apr 1;106(4):2700-15. https://www.sciencedirect.com/science/article/pii/S0022030223000644 

4. Truman CM, Campler MR, Costa JH. Body condition score change throughout lactation utilizing an automated BCS system: A descriptive study. Animals. 2022 Feb 28;12(5):601. https://www.mdpi.com/2076-2615/12/5/601 

5. Fry MM, Yao B, Ríos C, Wong C, Mann S, McArt JA, Nydam DV, Yepes FL, Viesselmann L, Geick A, Goldin K. Diagnostic performance of cytology for assessment of hepatic lipid content in dairy cattle. Journal of dairy science. 2018 Feb 1;101(2):1379-87. https://www.sciencedirect.com/science/article/pii/S0022030217311402 
6. Contreras GA, Strieder-Barboza C, De Koster J. Symposium review: Modulating adipose tissue lipolysis and remodeling to improve immune function during the transition period and early lactation of dairy cows. Journal of Dairy Science. 2018 Mar 1;101(3):2737-52. https://www.sciencedirect.com/science/article/pii/S0022030217309591